Cite
HARVARD Citation
Chaloupka, F. et al. (2015). An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation. Tobacco control. 24 (2), pp. 112-119. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chaloupka, F. et al. (2015). An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation. Tobacco control. 24 (2), pp. 112-119. [Online].